Its pipeline includes development programs in the areas of adjunctive thrombolytic therapy, heart failure, resuscitation and major trauma. The company develops MST-188 utilizing its proprietary technology molecular adhesion and sealant technology (MAST). The company is headquartered in San Diego, California, the US. Еще
